Lovastatin Tablet
Product Images NDC 66267-506

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lovastatin (NDC 66267-506). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

66267 506 90

66267 506 90
This is a description of a medication called Lovastatin 10mg made by NuCare Pharmaceuticals Inc. The medication is in tablet form, containing 90 tablets in a bottle. Each tablet contains Lovastatin 10mg and is round, white or off-white with an engraving of "CTi 141" on one side. The National Drug Code (NDC) for the medication is 66267-0506-90 with a lot number of 000000. The medication is for prescription use only, and the manufacturer's NDC is 61442-141-10 with a serial number of 00000000002. The medication should be stored at a controlled temperature of 68-77°F and kept out of reach of children. The text also includes a warning to consult a doctor before use and to contact the FDA if any negative side effects occur.*
FDA Label Image

Structural Formula (Lov00 0004 01)

FDA Label Image

Table I (Lov00 0004 02)

FDA Label Image

Figure 1 (Lov00 0004 03)

Figure 1 (Lov00 0004 03)
This figure is representing the proportion of participants who did not have an acute major coronary event, which is the primary endpoint, during the follow-up period of up to four years. If there were any additional details or labels, they were not captured by the .*
FDA Label Image

Table Vii (Lov00 0005 04)

Table Vii (Lov00 0005 04)
This is a table listing drug interactions associated with an increased risk of muscle damage (myopathy/rhabdomyolysis) when prescribed along with certain medications or substances. The table provides prescribing recommendations for healthcare professionals to avoid or limit the use of specific drugs or products when prescribing lovastatin, a medication commonly used to lower cholesterol. The table includes a list of strong CYP3A4 inhibitors, HIV protease inhibitors, boceprevir, telaprevir, nefazodone, cobicistat-containing products, gemfibrozil, cyclosporine, danazol, diltiazem, dronedarone, and grapefruit juice. The prescribing recommendations include avoiding or not exceeding specific dosage limits when used in combination with lovastatin.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.